NAVIGLIO, Silvio
 Distribuzione geografica
Continente #
EU - Europa 7.785
NA - Nord America 3.903
AS - Asia 2.969
SA - Sud America 391
AF - Africa 41
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 3
Totale 15.106
Nazione #
RU - Federazione Russa 4.561
US - Stati Uniti d'America 3.818
SG - Singapore 1.048
IT - Italia 940
IE - Irlanda 840
CN - Cina 698
HK - Hong Kong 417
BR - Brasile 334
GB - Regno Unito 333
UA - Ucraina 297
DE - Germania 296
VN - Vietnam 290
KR - Corea 151
IN - India 122
SE - Svezia 119
FI - Finlandia 105
FR - Francia 94
GR - Grecia 58
TR - Turchia 58
BD - Bangladesh 42
CA - Canada 42
JP - Giappone 40
BE - Belgio 36
MX - Messico 30
NL - Olanda 24
AR - Argentina 21
ID - Indonesia 15
ZA - Sudafrica 15
AT - Austria 14
PL - Polonia 14
AU - Australia 13
RO - Romania 11
IQ - Iraq 10
ES - Italia 9
EC - Ecuador 8
IR - Iran 8
JO - Giordania 8
EG - Egitto 7
AE - Emirati Arabi Uniti 6
KZ - Kazakistan 6
MA - Marocco 6
NO - Norvegia 6
PK - Pakistan 6
CH - Svizzera 5
PH - Filippine 5
PY - Paraguay 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
VE - Venezuela 5
BG - Bulgaria 4
CL - Cile 4
CO - Colombia 4
CZ - Repubblica Ceca 4
LT - Lituania 4
PE - Perù 4
UY - Uruguay 4
AZ - Azerbaigian 3
DZ - Algeria 3
EU - Europa 3
HU - Ungheria 3
MY - Malesia 3
NP - Nepal 3
PA - Panama 3
TH - Thailandia 3
TN - Tunisia 3
TW - Taiwan 3
BO - Bolivia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
OM - Oman 2
PR - Porto Rico 2
PT - Portogallo 2
SI - Slovenia 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
CY - Cipro 1
GA - Gabon 1
HR - Croazia 1
IL - Israele 1
KH - Cambogia 1
KY - Cayman, isole 1
LK - Sri Lanka 1
MN - Mongolia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
SV - El Salvador 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
Totale 15.106
Città #
Moscow 1.573
Dublin 837
Chandler 578
Singapore 498
Jacksonville 452
Santa Clara 424
Hong Kong 409
San Jose 378
Caserta 307
Ashburn 165
Naples 143
Seoul 142
Beijing 124
Princeton 101
Ann Arbor 92
Ho Chi Minh City 88
Medford 77
Hanoi 76
Bremen 71
New York 67
Roxbury 67
Boardman 64
Hefei 63
Bengaluru 56
Wilmington 52
Dallas 47
San Mateo 47
Munich 39
Napoli 38
Brussels 35
Los Angeles 34
Cambridge 33
Woodbridge 33
The Dalles 32
Houston 27
Mountain View 25
Orem 24
Helsinki 22
Nanjing 22
Chennai 21
London 20
Rome 20
São Paulo 20
Düsseldorf 19
Giugliano In Campania 19
Da Nang 18
Aversa 17
Milan 17
Jinan 16
Des Moines 15
Frankfurt am Main 15
Atlanta 13
Guangzhou 13
Tokyo 12
Zhengzhou 12
Belo Horizonte 11
Manchester 11
Mexico City 11
Tianjin 11
Toronto 11
Memphis 10
Mumbai 10
Warsaw 10
Amsterdam 9
Brooklyn 9
Changsha 9
Hanover 9
Hyderabad 9
Nuremberg 9
Ottawa 9
Turku 9
Amman 8
Boston 8
Haiphong 8
Mexico 8
Montreal 8
Norwalk 8
Orta di Atella 8
Piscataway 8
Rio de Janeiro 8
San Francisco 8
Stockholm 8
Venice 8
Auburn Hills 7
Campinas 7
Chicago 7
Columbus 7
New Delhi 7
Palermo 7
Salvador 7
Campofelice di Roccella 6
Canberra 6
Dong Ket 6
Jakarta 6
Mirabella Eclano 6
Porto Alegre 6
Redwood City 6
Shanghai 6
Taiyuan 6
Wuhan 6
Totale 7.991
Nome #
Histone deacetylase inhibitors increase p27Kip1 by affecting its ubiquitin-dependent degradation through Skp2 down-regulation 256
Lactic dehydrogenase and cancer: an overview 218
Adiponectin down-regulates CREB and inhibits proliferation of A549 lung cancer cells 212
Integrating Silybin and Sirtuin Related Pathways in Steatosis-Related Liver Diseases 198
cAMP elevation down-regulates beta3 integrin and Focal Adhesion Kinase and inhibits leptin-induced migration of MDA-MB-231 breast cancer cells 198
Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium 196
Forskolin potentiates the effects of GSKJ4 in human acute myeloid leukemia cells through Protein Kinase A pathway 195
Adenylate cyclase/cAMP pathway downmodulation counteracts apoptosis induced by IFN-alpha in human epidermoid cancer cells. 189
S-Adenosylmethionine Affects ERK1/2 and STAT3 Pathways and Induces Apoptosis in Osteosarcoma Cells. 187
Chlorogenic acid activates ERK1/2 and inhibits proliferation of osteosarcoma cells 187
The Natural cAMP Elevating Compound Forskolin in Cancer Therapy: Is it Time? 184
A novel G-protein active on signal transduction 183
5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress. 183
A Proteomic Approach Reveals That miR-423-5p Modulates Glucidic and Amino Acid Metabolism in Prostate Cancer Cells 181
Antiproliferative activity of the CGA-containing SiO2/PEG hybrids synthesized by sol-gel method 181
Naturally occurring molecules and anticancer combination therapies in the era of personalized medicine and economic crisis. 180
Change in TNF-alpha receptor expression is a relevant event in doxorubicin-induced H9c2 cardiomyocyte cell death 179
Biological influence of Ca/P ratio on calcium phosphate coatings by sol-gel processing 179
Antioxidant and Biocompatible 5-O-Caffeoylquinic Acid-Based Composite Materials 178
Adenylate Cyclase modulation by proteasome mediated αs accumulation in mammalian cells 173
Valutazione in vitro degli effetti cardiotossici da 5-Fluorouracile per la prevenzione dei danni cardiovascolari negli operatori sanitari professionalmente esposti. [Evaluation in vitro of the cardiotoxic effects of 5-fluorouracil for the prevention of cardiovascular damage in health workers occupationally exposed]. 172
Forskolin improves sensitivity to doxorubicin of triple negative breast cancer cells via Protein Kinase A-mediated ERK1/2 inhibition 170
Chemical analysis and anti-proliferative activity of Campania Thymus Vulgaris essential oil 169
Dapagliflozin protects the kidney in a non-diabetic model of cardiorenal syndrome 168
Dipeptidyl Peptidase 4 Inhibition Ameliorates Chronic Kidney Disease in a Model of Salt-Dependent Hypertension 166
Adenylate cyclase regulation via proteasome-mediated modulation of Galphas levels. 165
Inorganic Phosphate Prevents Erk1/2 and Stat3 Activation and Improves Sensitivity to Doxorubicin of MDA-MB-231 Breast Cancer Cells 163
cAMP pathway in differentiating myoblast 162
Chlorogenic acid enhances doxorubicin-mediated cytotoxic effect in osteosarcoma cells 161
Cellular response to PCL/ZrO2hybrid materials synthesized via sol-gel as a function of PCL content 160
Doxorubicin (DXR) treatment stimulates TNF-α expression in the rat cardiomyoblast cell line (H9c2), triggering mechanisms of auto-toxicity 158
Adiponectin Is Inversely Associated With Tumour Grade in Colorectal Cancer Patients 158
Financing Mental Health Facilities During the Economic Recession: Evidence from the Private Finance Initiative Policy in the United Kingdom. 155
Gli effetti della fosforilazione di proteine di membrana, PKC mediata, sull’attività adenilato ciclasica di piastrine umane 155
Chemical and Biological Characterization of Essential Oils Extracted from Thymus Vulgaris 155
Adiponectin Receptor Agonist AdipoRon Inhibits Proliferation and Drives Glycolytic Dependence in Non-Small-Cell Lung Cancer Cells 154
AdipoRon Affects Cell Cycle Progression and Inhibits Proliferation in Human Osteosarcoma Cells 153
Differentiation of H9c2 cardiomyoblasts: The role of adenylate cyclase system. 152
Forskolin affects proliferation, migration and Paclitaxel-mediated cytotoxicity in non-small-cell lung cancer cell lines via adenylyl cyclase/cAMP axis 150
Adenylate Cyclase activity in rat thyroid epithelial cells (PC-Cl3) treated in vivo with lovastatin 150
G-protein modulation of the adenylate cyclase (AC) activity in control and ras-virus transformed cells 150
Cross talk" between protein kinase C (PKC) and adenylate cyclase (AC) in human pleteletes. 149
Adiporon and other adiponectin receptor agonists as potential candidates in cancer treatments 149
Adenylate cyclase and cell cycle 148
Cholera toxin-mediated ADP-ribosylation " in vivo ": A useful tool for studying the G-protein cycle. 144
G-Protein modulation of the adenylate cyclase (AC) activity in control and Ras-virus transformed epithelial cells. 144
. Antioxidant and biocompatible 5-O-caffeoylquinic acid-based composite 144
Targeting protein kinase A in cancer therapy: an update. 141
Forskolin sensitizes pancreatic cancer cells to gemcitabine via Stat3 and Erk1/2 inhibition 141
Antibacterial Properties of Sol–Gel Biomaterials with Different Percentages of PEG or PCL 139
AdipoRon and Pancreatic Ductal Adenocarcinoma: a future perspective in overcoming chemotherapy-induced resistance? 138
Oxidative Stress and Cellular Response to Doxorubicin: A Common Factor in the Complex Milieu of Anthracycline Cardiotoxicity 137
Beneficial effects and perspective strategies for lycopene food enrichment: A systematic review 137
An update on the currently available and emerging synthetic pharmacotherapy for uncontrolled asthma 136
Red cell distribution width/platelet ratio estimates the 3-year risk of decompensation in Metabolic Dysfunction-Associated Steatotic Liver Disease-induced cirrhosis 136
Inorganic phosphate and cancer: its effects in osteosarcoma, breast and pancreatic cancer cells”. 135
Uncovering prognostic biomarkers through a pharmacovigilance study: the case of RDW 132
INHIBITION OF ONCOGENIC EFFECTS OF LEPTIN BY CAMP ELEVATION IN TRIPLE NEGATIVE BREAST CANCER CELLS 131
Ubiquitin/proteasome system and adenylate cyclase: their functional interrelations 130
Preoperative, postoperative and 1-year followup N-terminal pro-B-type natriuretic peptide levels in severe chronic aortic regurgitation: correlations with echocardiographic findings. 128
Targeting p27Kip1 protein: its relevance in the therapy of human cancer. 128
The influence of the polymer amount on the biological properties of PCL/ZrO2hybrid materials synthesized via sol-gel technique 128
Leptin enhances growth inhibition by cAMP elevating agents through apoptosis of MDA-MB-231 breast cancer cells 126
Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway. 125
Integrating Gemcitabine-Based Therapy With AdipoRon Enhances Growth Inhibition in Human PDAC Cell Lines 125
Treatment of v-Ki-ras-transformed SVC1 cells with low retinoic acid induces malignancy reversion associated with ras p21 down-regulation 123
Inorganic Phosphate as A Signaling Molecule: A Potential Strategy in Osteosarcoma Treatment 122
Inorganic phosphate as a new signalling molecule: effects on the adenylate cyclase/cAMP system 121
Inorganic phosphate in the development and treatment of cancer: A Janus Bifrons? 121
Synergistic cytotoxic effects of inorganic phosphate and chemotherapeutic drugs on human osteosarcoma cells. 121
Antibacterial properties of sol-gel biomaterials with different percentages of polymers 120
Inorganic phosphate inhibits growth of human osteosarcoma U2OS cells via adenylate cyclase/cAMP pathway 119
The phosphorylation degree of the proteins in the neoplastic epidermoid A431 cells is also affected by a Ca2+-calmodulin dependent modulation. 119
Retinoic acid modulates external signal metabolic pathways in SVCI and KiSVC1 epithelial cells. 119
TNF-alpha receptors expression level changes are a relevant event in Doxorubicin-induced H9c2 cardiomyocytes apoptosis 119
Valutazioni di metodiche di criopreservazione di piastrine umane sulla base di parametri fisici, biochimici e funzionali 118
Forskolin sensitizes human acute myeloid leukemia cells to H3K27me2/3 demethylases GSKJ4 inhibitor via Protein Kinase A 118
UBPY: a growth regulated human ubiquitin isopeptidase 116
Inorganic phosphate as a novel signalling molecule with antiproliferative action in MDA-MB-231 breast cancer cells 116
MAMMALIAN UBIQUITIN-ISOPEPTIDASES THAT CONTROL CELL PROLIFERATION 116
Combining AdipoRon with Paclitaxel Unveils Synergistic Potential in Non-Small Cell Lung Cancer Cells via AMPK-ERK1/2 Signaling 115
INORGANIC PHOSPHATE AS A NOVEL SIGNALING MOLECULE: ITS POTENTIAL USE IN THE OSTEOSARCOMA THERAPY 113
Meccanismi di regolazione delle attività fosfodiesterasiche in fegato di ratto 113
Regulatory mechanism of the soluble phosphodiesterase activities in rat liver. 112
Leptin affects adenylate cyclase activity in H9c2 cardiac cell line: effects of short- and long-term exsposure 112
LEPTIN POTENTIATES ANTIPROLIFERATIVE ACTION OF cAPM ELEVATION VIA PROTEIN KINASE A DOWN-REGULATION IN BREAST CANCER CELLS. 112
Protein Kinase A as a biological target in cancer therapy. 111
Effetti dell’espressione del cDNA della transglutaminasi tissutale umana sui livelli di attività GTPasica in cellule fibroblastiche murine 111
Integrating leptin and cAMP signalling pathways in triple-negative breast cancer cells. 111
The possible use of inorganic phosphate in osteosarcoma therapy 110
Leptin effect on adenylate cyclase/cAMP pathway in rat H9c2 myoblasts 109
Protein kinase activities in epidermoid cells (A431) 108
Novel molecular mechanisms by inorganic phosphate in osteosarcoma U2OS cells 107
Unravelling the Adiponectin Hallmark and Exploring the Therapeutic Potential of Its Receptor Agonists in Cancer Metabolic Reprogramming 106
ras oncogene-induced transformation of a rat seminal vesicle epithelial cell line produces a marked increase of adenylate cyclase and protein kinase C activities. 106
Protein kinase a detection in human urine samples 105
Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR. 104
Early effects by retinoic acid (RA) at the membrane level in eucaryotic cells. 103
Silica/Polyethylene glycol hybrid materials prepared by a sol-Gel method and containing chlorogenic acid 102
Relationships between doxorubicin (Doxo)-induced damage and TNF-α pathways in H9c2 cardiomyoblast 101
Totale 14.413
Categoria #
all - tutte 49.623
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.623


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202134 0 0 0 0 0 0 0 0 0 0 0 34
2021/2022746 50 5 11 34 228 8 7 54 40 46 56 207
2022/20231.889 123 80 26 201 206 161 6 137 836 29 33 51
2023/2024631 69 24 31 41 178 55 15 25 23 12 77 81
2024/20251.818 18 19 45 70 306 254 297 142 244 178 141 104
2025/20267.778 405 314 412 325 640 4.263 372 344 251 202 147 103
Totale 15.732